Genetic Technologies Limited (GNTLF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 3.9 Million AUD | -10.26% |
| 2023 | 4.35 Million AUD | -32.79% |
| 2022 | 6.47 Million AUD | 2792.02% |
| 2021 | -240.47 Thousand AUD | 0.49% |
| 2020 | -241.64 Thousand AUD | 3.66% |
| 2019 | -250.82 Thousand AUD | -126.31% |
| 2018 | -110.83 Thousand AUD | -524.83% |
| 2017 | 26.08 Thousand AUD | -68.0% |
| 2016 | 81.52 Thousand AUD | -92.73% |
| 2015 | 1.12 Million AUD | -58.9% |
| 2014 | 2.72 Million AUD | 90.44% |
| 2013 | 1.43 Million AUD | -84.74% |
| 2012 | 9.38 Million AUD | -42.23% |
| 2011 | 16.24 Million AUD | 130.69% |
| 2010 | 7.04 Million AUD | 78.77% |
| 2009 | 3.93 Million AUD | -73.47% |
| 2008 | 14.84 Million AUD | 106.35% |
| 2007 | 7.19 Million AUD | 292.75% |
| 2006 | 1.83 Million AUD | -62.27% |
| 2005 | 4.85 Million AUD | 716.49% |
| 2004 | 594.57 Thousand AUD | -93.58% |
| 2003 | 9.26 Million AUD | -29.32% |
| 2002 | 13.1 Million AUD | 132.68% |
| 2001 | 5.63 Million AUD | 40.17% |
| 2000 | 4.01 Million AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | -4.3 Million AUD | -199.03% |
| 2024 Q2 | -1.98 Million AUD | -227.14% |
| 2024 Q1 | 1.55 Million AUD | 227.37% |
| 2024 Q4 | -2.45 Million AUD | 0.0% |
| 2023 Q1 | 1.41 Million AUD | -51.63% |
| 2023 Q3 | 1.59 Million AUD | 202.9% |
| 2023 Q2 | -1.54 Million AUD | -209.28% |
| 2023 FY | 4.35 Million AUD | -32.79% |
| 2023 Q4 | -1.22 Million AUD | -176.88% |
| 2022 Q3 | 1.93 Million AUD | 161.65% |
| 2022 Q1 | 1.16 Million AUD | 415.36% |
| 2022 FY | 6.47 Million AUD | 2792.02% |
| 2022 Q2 | 741.18 Thousand AUD | -36.27% |
| 2022 Q4 | 2.92 Million AUD | 50.84% |
| 2021 Q4 | -368.79 Thousand AUD | -156.49% |
| 2021 Q1 | -83.29 Thousand AUD | 42.51% |
| 2021 Q2 | -270.22 Thousand AUD | -224.42% |
| 2021 Q3 | 652.86 Thousand AUD | 341.6% |
| 2021 FY | -240.47 Thousand AUD | 0.49% |
| 2020 Q1 | -96.95 Thousand AUD | 65.14% |
| 2020 Q2 | -206.07 Thousand AUD | -112.54% |
| 2020 Q3 | -23.86 Thousand AUD | 88.42% |
| 2020 Q4 | -144.88 Thousand AUD | -507.06% |
| 2020 FY | -241.64 Thousand AUD | 3.66% |
| 2019 Q4 | -278.12 Thousand AUD | -193.45% |
| 2019 Q1 | -30.63 Thousand AUD | -12.01% |
| 2019 Q2 | -30.63 Thousand AUD | 0.0% |
| 2019 FY | -250.82 Thousand AUD | -126.31% |
| 2019 Q3 | -94.77 Thousand AUD | -209.36% |
| 2018 Q3 | -27.35 Thousand AUD | 2.55% |
| 2018 Q1 | -28.06 Thousand AUD | -19.7% |
| 2018 FY | -110.83 Thousand AUD | -524.83% |
| 2018 Q2 | -28.06 Thousand AUD | 0.0% |
| 2018 Q4 | -27.35 Thousand AUD | -0.0% |
| 2017 Q2 | 36.49 Thousand AUD | 0.0% |
| 2017 FY | 26.08 Thousand AUD | -68.0% |
| 2017 Q4 | -23.44 Thousand AUD | 0.0% |
| 2017 Q3 | -23.44 Thousand AUD | -164.25% |
| 2017 Q1 | 36.49 Thousand AUD | 60.41% |
| 2016 Q3 | 22.74 Thousand AUD | 26.29% |
| 2016 Q4 | 22.74 Thousand AUD | 0.0% |
| 2016 Q2 | 18.01 Thousand AUD | 0.0% |
| 2016 Q1 | 18.01 Thousand AUD | -91.03% |
| 2016 FY | 81.52 Thousand AUD | -92.73% |
| 2015 FY | 1.12 Million AUD | -58.9% |
| 2015 Q4 | 200.74 Thousand AUD | 0.0% |
| 2015 Q3 | 200.74 Thousand AUD | 41.48% |
| 2015 Q2 | 141.88 Thousand AUD | 0.0% |
| 2015 Q1 | 141.88 Thousand AUD | -72.82% |
| 2014 Q4 | 522.11 Thousand AUD | 0.0% |
| 2014 FY | 2.72 Million AUD | 90.44% |
| 2014 Q1 | 301.55 Thousand AUD | 406.03% |
| 2014 Q2 | 301.55 Thousand AUD | -0.0% |
| 2014 Q3 | 522.11 Thousand AUD | 73.14% |
| 2013 FY | 1.43 Million AUD | -84.74% |
| 2013 Q4 | -98.53 Thousand AUD | 0.0% |
| 2013 Q3 | -98.53 Thousand AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 FY | 9.38 Million AUD | -42.23% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 FY | 16.24 Million AUD | 130.69% |
| 2011 Q2 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | 7.04 Million AUD | 78.77% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 FY | 3.93 Million AUD | -73.47% |
| 2008 FY | 14.84 Million AUD | 106.35% |
| 2008 Q2 | 3.65 Million AUD | -17.4% |
| 2008 Q1 | 4.42 Million AUD | -30.1% |
| 2008 Q4 | 3.33 Million AUD | -49.76% |
| 2008 Q3 | 6.63 Million AUD | 81.61% |
| 2007 Q1 | 2.7 Million AUD | 23.61% |
| 2007 FY | 7.19 Million AUD | 292.75% |
| 2007 Q2 | 1.33 Million AUD | -50.74% |
| 2007 Q3 | 4.24 Million AUD | 217.79% |
| 2007 Q4 | 6.32 Million AUD | 49.14% |
| 2006 FY | 1.83 Million AUD | -62.27% |
| 2006 Q1 | 3.37 Million AUD | 426.69% |
| 2006 Q2 | 2.69 Million AUD | -20.22% |
| 2006 Q3 | 2.56 Million AUD | -4.61% |
| 2006 Q4 | 2.19 Million AUD | -14.72% |
| 2005 Q2 | 2.28 Million AUD | -39.37% |
| 2005 FY | 4.85 Million AUD | 716.49% |
| 2005 Q1 | 3.76 Million AUD | 0.0% |
| 2005 Q3 | 3.55 Million AUD | 55.6% |
| 2005 Q4 | -1.03 Million AUD | -129.1% |
| 2004 FY | 594.57 Thousand AUD | -93.58% |
| 2003 FY | 9.26 Million AUD | -29.32% |
| 2002 FY | 13.1 Million AUD | 132.68% |
| 2001 FY | 5.63 Million AUD | 40.17% |
| 2000 FY | 4.01 Million AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 2123.044% |
| Arrayit Corporation | 2.57 Million USD | -51.627% |
| Atlantic International Corp. | -154.23 Thousand USD | 2631.526% |
| Biocept, Inc. | -2.58 Million USD | 251.219% |
| Bioqual, Inc. | 7.42 Million USD | 47.444% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -1314.664% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 99.942% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -117.63% |
| iMD Companies, Inc. | -23.63 Thousand USD | 16618.484% |
| IDenta Corp. | 662.97 Thousand USD | -488.932% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 83.056% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -4933.42% |
| InVitro International | 635.98 Thousand USD | -513.925% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | 40.508% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -257.329% |
| NovelStem International Corp. | 12 Thousand USD | -32437.283% |
| Optigenex Inc. | -102.96 Thousand USD | 3892.003% |
| PharmChem, Inc. | 3.9 Million USD | -0.003% |
| Proteome Sciences plc | 2.09 Million USD | -86.226% |
| Response Genetics, Inc | 3.94 Million USD | 0.952% |
| Rennova Health, Inc. | 6.26 Million USD | 37.71% |
| RushNet, Inc. | 1.1 Million USD | -253.469% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -355.824% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 1067.06% |
| Todos Medical Ltd. | 4.31 Million USD | 9.409% |